These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 12862135

  • 1. Safety and immunogenicity of an autoclaved Leishmania major vaccine.
    Khalil EA, Elhassan AM, Zijlstra EE, Osman OF, Eljack IA, Ibrahim ME, Mukhtar MM, Ghalib HW, Modabbers F.
    East Afr Med J; 2000 Sep; 77(9):468-70. PubMed ID: 12862135
    [Abstract] [Full Text] [Related]

  • 2. Safety and immunogenicity of a candidate vaccine for visceral leishmaniasis (Alum-precipitated autoclaved Leishmania major + BCG) in children: an extended phase II study.
    Khalil EA, Musa AM, Modabber F, El-Hassan AM.
    Ann Trop Paediatr; 2006 Dec; 26(4):357-61. PubMed ID: 17132302
    [Abstract] [Full Text] [Related]

  • 3. Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan.
    Khalil EA, El Hassan AM, Zijlstra EE, Mukhtar MM, Ghalib HW, Musa B, Ibrahim ME, Kamil AA, Elsheikh M, Babiker A, Modabber F.
    Lancet; 2000 Nov 04; 356(9241):1565-9. PubMed ID: 11075771
    [Abstract] [Full Text] [Related]

  • 4. Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment.
    Musa AM, Khalil EA, Mahgoub FA, Elgawi SH, Modabber F, Elkadaru AE, Aboud MH, Noazin S, Ghalib HW, El-Hassan AM, Leishmaniasis Research Group/Sudan.
    Trans R Soc Trop Med Hyg; 2008 Jan 04; 102(1):58-63. PubMed ID: 17963805
    [Abstract] [Full Text] [Related]

  • 5. Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.
    Sharifi I, FeKri AR, Aflatonian MR, Khamesipour A, Nadim A, Mousavi MR, Momeni AZ, Dowlati Y, Godal T, Zicker F, Smith PG, Modabber F.
    Lancet; 1998 May 23; 351(9115):1540-3. PubMed ID: 10326536
    [Abstract] [Full Text] [Related]

  • 6. Alum-precipitated autoclaved Leishmania major plus bacille Calmette-Guérrin, a candidate vaccine for visceral leishmaniasis: safety, skin-delayed type hypersensitivity response and dose finding in healthy volunteers.
    Kamil AA, Khalil EA, Musa AM, Modabber F, Mukhtar MM, Ibrahim ME, Zijlstra EE, Sacks D, Smith PG, Zicker F, El-Hassan AM.
    Trans R Soc Trop Med Hyg; 2003 May 23; 97(3):365-8. PubMed ID: 15228261
    [Abstract] [Full Text] [Related]

  • 7. The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis.
    Alimohammadian MH, Khamesipour A, Darabi H, Firooz A, Malekzadeh S, Bahonar A, Dowlati Y, Modabber F.
    Vaccine; 2002 Dec 13; 21(3-4):174-80. PubMed ID: 12450691
    [Abstract] [Full Text] [Related]

  • 8. Immunogenicity and safety of autoclaved Leishmania major plus BCG vaccine in healthy Sudanese volunteers.
    Satti IN, Osman HY, Daifalla NS, Younis SA, Khalil EA, Zijlstra EE, El Hassan AM, Ghalib HW.
    Vaccine; 2001 Feb 28; 19(15-16):2100-6. PubMed ID: 11228382
    [Abstract] [Full Text] [Related]

  • 9. A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran.
    Momeni AZ, Jalayer T, Emamjomeh M, Khamesipour A, Zicker F, Ghassemi RL, Dowlati Y, Sharifi I, Aminjavaheri M, Shafiei A, Alimohammadian MH, Hashemi-Fesharki R, Nasseri K, Godal T, Smith PG, Modabber F.
    Vaccine; 1999 Feb 05; 17(5):466-72. PubMed ID: 10073725
    [Abstract] [Full Text] [Related]

  • 10. Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis.
    Armijos RX, Weigel MM, Calvopina M, Hidalgo A, Cevallos W, Correa J.
    Vaccine; 2004 Mar 12; 22(9-10):1320-6. PubMed ID: 15003662
    [Abstract] [Full Text] [Related]

  • 11. Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran.
    Mohebali M, Khamesipour A, Mobedi I, Zarei Z, Hashemi-Fesharki R.
    Vaccine; 2004 Sep 28; 22(29-30):4097-100. PubMed ID: 15364462
    [Abstract] [Full Text] [Related]

  • 12. Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG.
    Mahmoodi M, Khamesipour A, Dowlati Y, Rafati S, Momeni AZ, Emamjomeh M, Hejazi H, Modabber F.
    Clin Exp Immunol; 2003 Nov 28; 134(2):303-8. PubMed ID: 14616791
    [Abstract] [Full Text] [Related]

  • 13. Failure of a killed Leishmania amazonensis vaccine against American cutaneous leishmaniasis in Colombia.
    Vélez ID, Gilchrist K, Arbelaez MP, Rojas CA, Puerta JA, Antunes CM, Zicker F, Modabber F.
    Trans R Soc Trop Med Hyg; 2005 Aug 28; 99(8):593-8. PubMed ID: 15893351
    [Abstract] [Full Text] [Related]

  • 14. Field trial of a vaccine against new world cutaneous leishmaniasis in an at-risk child population: how long does protection last?
    Armijos RX, Weigel MM, Romero L, Garcia V, Salazar J.
    J Infect Dis; 2003 Jun 15; 187(12):1959-61. PubMed ID: 12792873
    [Abstract] [Full Text] [Related]

  • 15. The adjuvant effects of IL-12 and BCG on autoclaved Leishmania major vaccine in experimental cutaneous leishmaniasis.
    Michel MY, Fathy FM, Hegazy EH, Hussein ED, Eissa MM, Said DE.
    J Egypt Soc Parasitol; 2006 Apr 15; 36(1):159-76, following 76. PubMed ID: 16605109
    [Abstract] [Full Text] [Related]

  • 16. [Concordance of leishmaniasis cutaneous tests in Tunisia].
    Ben Alaya Bouafif N, Ben Salah A, Louzir H, Zaâtour A, Bel Haj Hamida N, Mighri F, Gharbi A, Gramiccia M, Gradoni L, Dellagi K, Ben Ismaïl R.
    Arch Inst Pasteur Tunis; 2001 Apr 15; 78(1-4):11-6. PubMed ID: 14658234
    [Abstract] [Full Text] [Related]

  • 17. Prophylactic potential of autoclaved Leishmania donovani with BCG against experimental visceral leishmaniasis.
    Srivastava JK, Misra A, Sharma P, Srivastava B, Naik S, Dube A.
    Parasitology; 2003 Aug 15; 127(Pt 2):107-14. PubMed ID: 12954011
    [Abstract] [Full Text] [Related]

  • 18. Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors.
    Schenkel K, Rijal S, Koirala S, Koirala S, Vanlerberghe V, Van der Stuyft P, Gramiccia M, Boelaert M.
    Trop Med Int Health; 2006 Dec 15; 11(12):1792-9. PubMed ID: 17176343
    [Abstract] [Full Text] [Related]

  • 19. Double-Blind Randomized Efficacy Field Trial of Alum Precipitated Autoclaved Leishmania major (Alum-ALM) Vaccine Mixed With BCG Plus Imiquimod Vs. Placebo Control Group.
    Barati M, Mohebali M, Alimohammadian MH, Khmesipour A, Keshavarz H, Akhoundi B, Zarei Z.
    Iran J Parasitol; 2015 Dec 15; 10(3):351-9. PubMed ID: 26622290
    [Abstract] [Full Text] [Related]

  • 20. A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis.
    Chakravarty J, Kumar S, Trivedi S, Rai VK, Singh A, Ashman JA, Laughlin EM, Coler RN, Kahn SJ, Beckmann AM, Cowgill KD, Reed SG, Sundar S, Piazza FM.
    Vaccine; 2011 Apr 27; 29(19):3531-7. PubMed ID: 21414377
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.